We welcome your feedback and you can help us to continue to improve our website by turning survey cookies on. Among them is the high cost associated with the per dose vaccine volume. ", Evaluate, Leading companies based on global vaccine revenue in 2019 (in million U.S. dollars) Statista, https://www.statista.com/statistics/1104110/top-global-pharma-companies-by-vaccine-revenue/ (last visited September 23, 2020), We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. The suspension of immunization campaigns and a decrease in the vaccination rate has generated enormous load on healthcare systems thus increasing the mortality rates by making population susceptible to the deadly antigens. You can find more information on how we use our cookies in our Cookie Statement. The increasing population of countries such as China and India is the major factor responsible for the demand for injections. Quick Analysis with our professional Research Service: Content Marketing & Information Design for your projects: Industry-specific and extensively researched technical data (partially from exclusive partnerships). Learn more about how Statista can support your business. The COVID-19 pandemic has currently affected more than 200 countries worldwide. Though international organizations are playing their best part in supplying millions of volume doses to every corner of the country, still there are many parts to receive vaccination amid their high cost. To sum-up, the COVID-19 outbreak has significantly lowered the adoption of vaccines. When you save your analytics cookies choice below, a cookie will be saved on your device to remember your choice.
A paid subscription is required for full access. High Cost Associated with Vaccine Dose to Limit Adoption. In addition, the report offers a thorough abstract on the statistics, market estimates and revenue forecasts, which further highlights its position in the industry, in tandem with the growth strategies adopted by leading industry players. * All products require an annual contract; Prices do not include sales tax.
For details, please see your browser’s Help section (by pressing F1). This is the current pharmaceutical challenge for all the companies before planning to launch into the market.
GSK, Merck, Sanofi, and Pfizer also are potential pipeline candidates that are expected to grow & contribute positively to the market growth.
Standard rate. The recombinant/conjugate/subunit segment is expected to be the leading segment in this market during the forecast period. Adult injection products are anticipated to register a higher CAGR owing to a rise in research & development of this segment, and a strong pipeline with upcoming product launch is likely to increase the growth of the segment during the forecast period. The report was very accurate and as per my requirements. The pandemic has brought a halt to the regular immunization programs conducted by UNICEF, WHO, PAHO, and other organizations. North America generated a revenue of USD 24.88 billion in 2019 and is anticipated to emerge dominant in the global market during the forecast period. You only have access to basic statistics. According to UNICEF in May 2020, 99 countries reported the termination of the immunization campaigns for measles/rubella, polio, meningococcal, DTP, and many other antigens. Strong vaccine supplies in the emerging nations, robust R&D for the introduction of novel products, competitive pipeline candidates, and powerful government support and funding are factors driving the market. Steady and dominant growth of the market in North America due to the number of factors that includes vaccination awareness, the presence of strong manufacturers, and secure government policy regarding health welfare. Growing at a CAGR of 10.7%, the market will exhibit remarkable growth in the forecast period (2020-2027). Growing Vaccines Supply by UNICEF, WHO, PAHO to Aid Immunization Process. Government surveillance in all the countries has become active in ensuring that every individual is vaccinated by recommended ones at a minimum cost or no cost. There has been a relatively slower vaccination rate in low and middle-income countries. These organizations procure the volume dose from the manufacturers in millions and mainly focus on supplying to countries having the lesser reach. Vaccines generate billions of dollars in revenue for drug companies as costs paid by the federal government — which purchases half of all the vaccines for the nation's children — have risen 15-fold since 1986, The New York Times reported. Another critical factor driving the vaccine market is the competitive pipeline, including products of major as well as emerging players. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the advanced market over recent years. facts. It was developed by Sanofi and MSD under joint-partnership. The vaccines market research report provides a detailed analysis of the market and focuses on key aspects such as leading companies, product types, and leading applications of the product.
Flu Vaccine Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Flu Vaccine Market place for the forecast 2019- 2025. Fortune Business Insights says that the global vaccines market size was USD 46.88 billion in 2019 and is projected to reach USD 104.87 billion by 2027. North America Vaccines Market Size, 2019 (USD Billion), To get more information on the regional analysis of this market, Request a Free sample. Section: 46(1)(a) According to the GAVI, the ceasing of immunizations will result in a lack of vaccination of about 13.5 million people from the least developed countries. The potential size of these are mainly dependent on two factors; worldwide growing birth cohort and increasing pediatric vaccination doses.